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ATP is a major chemical transmitter in purinergic signal transmission.  Before 
secretion, ATP is stored in secretory vesicles found in purinergic cells.  Although the 
presence of active transport mechanism(s) for ATP has been postulated for a long time, 
the protein(s) responsible for its vesicular accumulation remains unknown.  The 
transporter encoded by the human and mouse SLC17A9 gene, a novel member of an 
anion transporter family, was predominantly expressed in the brain and adrenal 
gland.  The mouse and bovine counterparts were associated with adrenal chromaffin 
granules.  Proteoliposomes containing purified transporter actively took up ATP, 
ADP and GTP using membrane potential as the driving force.  The uptake properties 
of the reconstituted transporter were similar to that of the ATP uptake by synaptic 
vesicles and chromaffin granules.  Suppression of endogenous SLC17A9 expression 
in PC12 cells decreased exocytosis of ATP.  These findings strongly suggest that 
SLC17A9 protein is a vesicular nucleotide transporter and should lead to the 
elucidation of the molecular mechanism of ATP secretion in purinergic signal 
transmission.    
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Vesicular storage and subsequent exocytosis of neurotransmitters is essential for chemical 
transmission in neurons and endocrine cells.  Thus far four distinct classes of transporters 
are known to participate in the uptake of neurotransmitters into neuronal synaptic vesicles 
and secretory granules in endocrine cells.  These are vesicular monoamine transporters 
(VMAT), vesicular acetylcholine transporters (VAchT), vesicular inhibitory amino acid 
transporters (VIAAT) and vesicular glutamate transporters (VGLUT) (1-7).  These 
vesicular transporters mediate the active accumulation of the respective neurotransmitters 
through an electrochemical gradient of protons across the membrane generated by vacuolar 
proton-ATPase.  ATP is stored in secretory vesicles and subsequently exocytosed, which 
leads to the various purinergic responses such as central control of autonomic functions, 
pain and mechanosensory transduction, neural-glial interactions, control of vessel tone and 
angiogenesis, and platelet aggregation through purinoceptors, thus establishing its role as a 
chemical transmitter (8-12).  Since the concentration of nucleotides in the vesicles was 
maintained at around 0.1 to 1 M, an active transport mechanism(s) to accumulate 
nucleotides has been postulated (8-18).  Although evidence increasingly supports the 
presence of a vesicular ATP transporter(s) in secretory vesicles such as synaptic vesicles 
and adrenal chromaffin granules (13-19), the protein(s) responsible for the ATP 
accumulation has not yet been identified.   
       Here, we report the expression and function of human and mouse SLC17A9, a 
novel isoform of SLC17 phosphate transporter family.  We present evidence that the 
SLC17A9 protein acts as a vesicular nucleotide transporter and that it plays an essential role 
in vesicular storage of ATP in the ATP-secreting cells.    
 
Results and discussion 
Gene Organization and Expression of SLC17A9.  SLC17 is a type I phosphate 
transporter family consisting of eight genes that are classified into three distinct subfamilies: 
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a) SLC17A1-4 (NPT1, NPT3, NPT4 and Na+/PO42-cotransporter homologue), Na+ and 
inorganic phosphate co-transporters, b) SLC17A5 (sialin), a lysosomal H+/sialic acid 
co-transporter and c) SLC17A6-8, vesicular glutamate transporters (VGLUT) (5).  We 
found that a fourth subfamily tentatively designated SLC17A9 was identified in a genome 
data bank screening (Fig. 1A).  SLC17A9 was located on chromosome 20 and contained 
14 exons and 13 introns (supporting information (SI) Fig. 7).  The SLC17A9 protein was 
430 amino acid residues long with 12 putative transmembrane helices with around 23 - 29% 
identity and 41 - 48% similarity to that of other SLC17 members (Fig. 1B and SI Fig. 8).  
Orthologues of other mammalian species have been identified.  Although amino acid 
sequences of the amino terminal region in mammals exhibited species-specific variation, the 
remaining regions showed the relatively well-conserved features (83% identity) (SI Fig. 9).   
       We cloned cDNA encoded SLC17A9 (SI Fig. 8).  Northern blot analysis indicated 
that the SLC17A9 and mouse counterpart (mSLC17A9) were widely expressed in various 
organs, but predominantly in the adrenal gland, brain and thyroid gland (Fig. 2A).  In 
mouse adrenal gland, the mSLC17A9 protein was specifically expressed in the medulla and 
was associated with chromaffin granules (Fig. 2B,C).  The presence of a SLC17A9 
counterpart in bovine adrenal chromaffin granule membrane has been confirmed (Fig. 2D).     
 
SLC17A9 protein is an ATP transporter.  We hypothesized that SLC17A9 is 
responsible for the storage of nucleotides in chromaffin granules, in which high 
concentrations of ATP and other nucleotides (~0.2 M) are accumulated in a membrane 
potential (Δψ)-dependent manner (8, 13, 16).  To test this working hypothesis, the 
SLC17A9 protein was expressed in High Five cells, solubilized from the membranes and 
purified by Ni-NTA column chromatography (Fig. 3A).  The purified fraction showed two 
major protein bands (68 and 63kDa) on SDS polyacrylamide gel, which corresponded to 
SLC17A9 protein because of their immunological reactivity to anti-SLC17A9 antibodies 
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and ability to bind ATP upon UV light illumination (Fig. 3A).  The observation of two 
SLC17A9 protein bands upon polyacrylamide gel electrophoresis could have been due to 
conformational differences or modification.   
       We then reconstituted SLC17A9 protein into liposomes, and investigated whether 
or not the proteoliposomes took up [α-32P]ATP.  When an internal inside positive Δψ was 
established such as a K+-diffusion potential through the addition of valinomycin, the 
proteoliposomes took up [α-32P]ATP in a time-dependent manner (Fig. 3B, C and SI Table 
1).  ATP uptake was not observed in liposomes that did not contain SLC17A9 protein 
even when Δψ was already established (Fig. 3C).  In contrast, artificially imposing pH 
gradient (ΔpH) did not evoke the ATP uptake (SI Table I).  The valinomycin-evoked ATP 
uptake exhibited dose-dependence with Km and Vmax values of 0.8 mM and 138 
nmol/min/mg protein, respectively (Fig. 3C).  These results demonstrated that the 
SLC17A9 protein was an active transporter of ATP and used Δψ (positive inside) but not 
ΔpH (acidic inside) as the driving force.  
 
Characterization of Nucleotide Transport.  We further characterized the ATP uptake by 
SLC17A9 protein.  Since ATP is a trivalent anion at the physiological pH and behaves as 
a monovalent anion upon chelation with divalent cations such as Mg2+, we asked which 
forms were recognized as transport substrates.  We found that Mg2+ and Ca2+ did not 
affect the ATP uptake (Fig. 4A), suggesting that this transporter recognized ATP as a 
substrate irrespective of its charge status.  Cl- dependence on the ATP uptake is of interest 
because VGLUT, another subfamily of SLC17, absolutely requires Cl- for transport activity 
(20), and Cl- stimulates ATP uptake in chromaffin granule membrane vesicles (16).  As 
expected, the presence of Cl- was an absolute requirement for ATP transport activity in the 
SLC17A9 protein (Fig. 4B).  The transport activity reached steady state at ~4 mM Cl-, 
while the magnitude of Δψ was unchanged.  Br- also activated ATP transport, while 
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sulfate was not effective (SI Fig. 10).  Various anions such as iodine and thiocyanate were 
rather inhibitory.  The anion dependence of the SLC17A9 protein was similar to that of 
VGLUT (21, 22), suggesting the presence of a similar anion binding site and regulatory 
mechanism in this transporter family. Cis-inhibition studies suggested that this transporter 
preferentially recognized ATP, GTP and ADP as transport substrates.  AMP-PNP and 
γS-ATP, non-hydrolysable ATP analogues, and diadenosine triphosphate (AP3A), one of 
the unique physiological ATP derivatives that accumulates in chromaffin granules and 
synaptic vesicles (9, 18), strongly inhibited the uptake.  In contrast, adenosine and adenine 
were less effective inhibitors (Fig. 4C).  The transporter-mediated uptake of GTP and ADP 
was confirmed by the direct measurement of ADP and GTP uptake (Fig. 4D).  The ATP 
uptake was greatly inhibited by 4,4’-diisothiocyanatostilbene-2, 2’-disulfonate (DIDS), an 
inhibitor of VGLUT (23).  The concentration required for 50% inhibition (ID50) was 1.5 
μM (Fig. 4E).  DIDS also inhibited the uptake of GTP and ADP (Fig. 4D). Evans blue, a 
specific inhibitor of VGLUT (23), also potently inhibited the ATP uptake with an ID50 of 
40 nM (Fig. 4F).  Atractyloside, an inhibitor of the mitochondrial ATP/ADP exchanger, 
inhibited the ATP uptake of the SLC17A9 protein only in the presence of Mg2+ as reported 
for ATP uptake in chromaffin granules (16) (Fig. 4G).  Thus, the SLC17A9 protein is a 
Cl--dependent nucleotide transporter, whose properties are very similar, if not identical, to 
those observed for ATP uptake in chromaffin granules (8, 13, 15-17).   
 
Involvement of SLC17A9 protein in vesicular storage and exocytosis of ATP.  Finally, 
we investigated whether SLC17A9 is responsible for vesicular storage and subsequent 
exocytosis of ATP in purinergic cells.  PC12 cells are known to store and secrete ATP 
through secretory granule-mediated exocytosis (24).  We found that mSLC17A9 protein 
was associated with secretory granules (Fig. 5A) and that RNA interference suppressed 
about 53% of SLC17A9 expression and about 50% of KCl-stimulated exocytosis of ATP 
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from PC12 cells, while the control treated with scrambled siRNA did not show any 
inhibitory effect (Fig. 5B and C).  These results supported the participation of SLC17A9 
protein in vesicular storage and exocytosis of ATP.   
 
SLC17A9 protein as a vesicular nucleotide transporter.  Based on this information, we 
concluded that SLC17A9 and its orthologues encode the vesicular nucleotide transporter 
(VNUT).  SLC17A9 protein may accumulate ATP and other nucleotides in the secretory 
vesicles such as adrenal chromaffin granules and synaptic vesicles.  SLC17A9 protein is a 
long-searched nucleotide transporter and seems to be a missing link in purinergic chemical 
transmission (Fig. 6).  Our immunohistochemical studies with anti-mSLC17A9 antibodies 
indicated that mSLC17A9 protein is expressed in a population of astrocytes, suggesting 
involvement of this transporter in storage and subsequent exocytosis of ATP from these 
cells (manuscript in preparation) (25-27).  Thus, identification of SLC17A9 protein as a 
vesicular nucleotide transporter may reveal the molecular mechanisms how ATP is secreted 
from purinergic cells, and provide a novel molecular target for the pathophysiology of 
purinergic signaling and its therapeutic potential (9-11).  Phylogenetic analysis indicates 
that the orthologues of SLC17A9 are widely distributed among various invertebrates as 
well as vertebrates (SI Fig. 11).  Thus, our findings suggest the occurrence of common 
molecular mechanisms of the purinergic chemical transmission in animals.   
 
 
Materials and Methods 
Expression and purification of SLC17A9 protein.  Recombinant baculovirus 
containing human SLC17A9 cDNA were constructed using the Bac-to-Bac 
baculovirus expression systems (Invitrogen) according to the manufacture’s protocol.  
SLC17A9 cDNA was amplified by PCR using the primers (5'- 
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CACCATGACCCTGACAAGCAGGCGCCAGGA -3' and 5'- 
CTAGAGGTCCTCATGGGTAGAGCTC -3').  Sf9 or High Five cells were used for 
expression of SLC17A9 protein.  Insect cells were infected by recombinant 
baculoviruses at a multiplicity of infection (m. o. i.) of 2 and cultured a further 72 h for 
Sf9 cells and 48 h for High Five cells.  The cell (1~2 x 108 cells) were suspended in a 
buffer containing 20 mM Tris-HCl, pH 8.0, 0.1 M potassium acetate, 10% glycerol, 0.5 
mM dithiothreitol, 10 μg/ml pepstatin A and 10 μg/ml leupeptin and disrupted by 
sonication with a TOMY UD200 tip sonifier.  Cell lysates were centrifuged at 700 x g 
for 10 min to remove debris and the resultant supernatant was centrifuged at 160,000 x 
g for 1 h.  The pellet (membrane fraction) was suspended in buffer containing 20 mM 
MOPS-Tris, pH 7.0, 10% glycerol, 10 μg/ml pepstatin A and 10 μg/ml leupeptin at 
approximately 6 mg protein/ml, and was solubilized with 2% octylglucoside.  After 
centrifugation at 260,000 x g for 30 min, the supernatant was taken and applied to 1 ml 
of Ni-NTA Superflow resin (Qiagen).  After incubation for 4 h at 4°C, the resin was 
washed with 10 ml of 20 mM MOPS-Tris pH 7.0, 5 mM imidazole, 20% glycerol and 
1% octylglucoside.  SLC17A9 protein was eluted from the resin with 3 ml of the 
same buffer containing 60 mM imidazole and could be stored at -80°C without loss of 
activity for at least a few months. 
 
Reconstitution.  Reconstitution of purified SLC17A9 protein into liposomes was carried 
out by the freeze-thaw method as described (20).  In brief, 10 μg SLC17A9 protein was 
mixed with asolectin liposomes (0.5 mg lipid), frozen at -80°C and left at this temperature 
for at least 5 min.  The mixture was thawed quickly by holding the samples tube in the 
hands and diluted 60-fold with reconstitution buffer containing 20 mM MOPS-Tris, pH 
7.0, 0.5 mM dithiothreitol, 0.15 M sodium acetate and 2 mM magnesium acetate.  
Reconstituted proteoliposomes were sedimented by centrifugation at 200,000 x g for 1 h 
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at 4°C, suspended in 0.2 ml of 20 mM MOPS-Tris, pH 7.0 containing 0.15 M sodium 
acetate and 2 mM magnesium acetate, and used within a day of preparation.  Asolectin 
liposomes were prepared as follows: soybean lecithin (20 mg; Sigma Type IIS) was 
suspended in 2 ml of 20 mM MOPS-NaOH, pH 7.0 containing 0.5 mM dithiothreitol.  
The mixture was sonicated in a bath-type sonicator until clear, divided into small aliquots 
and stored at -80°C until use.  
 
Nucleotides transport.  Reconstituted proteoliposomes (0.5 μg protein per assay) 
were suspended in 500 μl of 20 mM MOPS-Tris, pH 7.0, 5 mM magnesium acetate, 4 
mM KCl and 0.15 M potassium acetate and incubated for 3 min at 27°C.  
Valinomycin was added to give a final concentration of 2 μM and the mixture 
incubated for a further 3 min.  The assay was initiated by addition of 0.1 mM [α-32P] 
ATP (3.7 GBq/mmol) and 130 μl aliquots were taken at the times indicated and 
centrifuged through a Sephadex G-50 (fine) spin column at 760 x g for 2 min (20).  
Radioactivity and protein concentration of the eluate were measured.  In the case of 
GTP or ADP transport, [α-32P] GTP (3.7 GBq/mmol ) or [2, 8-3 H] ADP (0.37 
GBq/mmol) were used for the substrates instead of ATP.   
 
Cell culture and RNA interference (RNAi) 
PC12 cells were cultured as described (24).  HiPerFect transfection reagent (Qiagen) 
was used for transfection of 25 nM AllStars negative control siRNA or rat SLC17A9 
siRNA: UAUUCGAGAGAAUGUCACG.  KCl-stimulated ATP secretion was 
assayed as described 3 days later (24). 
 
Data analysis.  All numerical values are shown as the mean + SEM. n = 3-6. Statistical 
significance was determined by the Student’s t-test.  * <0.1, ** < 0.01, *** < 0.001. 
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Northern blot analysis, cDNA cloning, immunohistochemistry and other detailed 
methods are provided in SI Supplementary materials and methods. 
. 
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Figure Legends 
 
Figure 1.  Phylogenetic tree of SLC17 family (A) and putative secondary structure of 
SLC17A9 protein (B).   
 
Figure 2.  Expression of SLC17A9 and its association with chromaffin granules. (A) 
Northern blotting showing expression of SLC17A9 in human and mouse brain and adrenal 
gland.  Expression of G3PDH is also shown as a control.  (B) Immunohistochemical 
localization of SLC17A9 protein in mouse adrenal gland.  Inset shows control staining 
with preabsorbed antibodies.  C, cortex; M, medulla. Bar = 10 μm. (C) 
Immunoelectronmicroscopy showing that SLC17A9 proteins (gold particles) are associated 
with chromaffin granules.  The inset shows background labeling with control serum.  Mit, 
mitochondrion.  Bar = 100 nm. (D) Western blot indicates the presence of a SLC17A9 
counterpart in the membrane of bovine adrenal chromaffin granule with a relative mobility 
of 61 kDa.  The preabsorbed antibodies did not bind to the protein.  The positions of 
marker proteins are indicated on the left.   
 
Figure 3.  Purification and reconstitution of SLC17A9 protein.  (A) Purification. (left) 
Purified fraction (7 μg protein) was analyzed in an 11% polyacrylamide gel electrophoresis 
in the presence of SDS and visualized by Coomassie Brilliant Blue staining. (center) A 
duplicate gel was analyzed by Western blotting with anti-SLC17A9 antibodies. (right) 
Labeling of SLC17A9 protein upon UV light illumination with [α-32P]ATP.  (B) 
Formation of Δψ (positive inside) was measured by oxonol-V fluorescence quenching.  
Proteoliposomes (0.5 μg protein) or liposomes (20 μg lipid) containing trapped Na+ was 
suspended in buffer containing 0.15 M K-acetate plus 4 mM KCl and 1 mM oxonol-V and 
fluorescence quenching was measured.  Final concentration of valinomycin and CCCP 
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were added at 1 μM. (C) Time course of [α-32P]ATP uptake. Na+-trapped proteoliposomes 
or liposomes were suspended as above in the presence or absence of valinomycin.  Upon 
the addition of [α-32P]ATP, samples were taken at the indicated times and radioactivity 
taken up by the proteoliposomes was counted. Inset. Dose dependence of ATP uptake.  
 
Figure 4.  Characterization of nucleotides transport by SLC17A9 protein. (A) The effect of 
divalent cations on the [α-32P]ATP uptake in the absence or presence of 2 mM Mg2+ or Ca2+ or 
0.5 mM EGTA. (B) Dependence of [α-32P]ATP uptake on [Cl-]. The uptake was measured after 
2 min.  Part of the potassium acetate in the reaction mixture was replaced with the indicated 
concentration of KCl.  The magnitude of Δψ (oxonol V-fluorescence quenching) was little 
affected under the assay conditions employed.  (C) [α-32P]ATP uptake in the presence of 
various nucleotides at 1 mM. (D) Uptake of radiolabeled GTP or ADP transport in the presence 
or absence of valinomycin.  When indicated, DIDS at 2 μM was included. (E-G) The effect of 
DIDS, Evans blue and atractyloside on [α-32P]ATP uptake in the presence or absence of 
Mg-acetate. Atractyloside was included at 200 μM. 
 
Figure 5.  The impact of rat SLC17A9 siRNA on the endogenous expression of SLC17A9 in 
in PC12 cells was compared to cells treated with scrambled siRNA (control).  (A) Double 
labeling immunohistochemistry indicated that SLC17A9 protein was co-localized at least in part 
with synaptotagmin, a marker of secretory granule, but not with synaptophysin, a marker of 
synaptic-like microvesicles in cultured PC12 cells. (B, C) Both SLC17A9 mRNA levels (B), as 
determined by real-time PCR, and the KCl-dependent secretion of ATP after 30 min (C) were 
assessed.  n= 9, 3 independent experiments.   
 
Figure 6.  Schematic presentation of purinergic chemical transmission.  VNUT is present in 
secretory vesicles and is responsible for vesicular storage of nucleotides.  The accumulated 
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nucleotides, in particular ATP, are exocytosed upon stimulation, bind to purinoceptors at the 
surface of target cells which then triggers intracellular signal transmission. 
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Supplementary materials and methods 
cDNAs.  cDNA of SLC17A9 was cloned by PCR from Mammalian Gene Collection clone 
4563089.  For the construction of cDNA, we used pENTR Directional TOPO cloning Kits 
(Invitrogen). The primers used were based on database sequences (Genbank No. CAC28600): 
sense primer, CACCATGACCCTGACAAGCAGGCGCCAGGA; antisense primer, 
CTAGAGGTCCTCATGGGTAGAGCTC. The sequence was confirmed by comparison with 
the human genome sequence and any differences corrected.  cDNAs of mouse SLC17A9 was 
cloned as described above. cDNA of mouse SLC17A9 was amplified by RT-PCR using RNA 
derived from mouse adrenal gland.  The following primers were used; sense primer, 
5’- CACCATGCCATCCCAGCGCTCTA-3’, antisense primer, 5’- 
TTCACTGACAGGGTTGTTATCC -3’.   
 
Northern blot analysis.  Human and mouse multiple-tissue Northern blots (MTN) were 
purchased from Clontech.  For Northern blot analysis, PCR fragments encoding the 
N-terminal 425 bps (223-647) of human SLC17A9 and C-terminal 758 bps (891 – 1648) 
of mouse SLC17A9 labeled with 32P-dCTP were used as probes.  Hybridization was 
performed at 68 oC for 1 h in Express Hyb hybridization solution (Clontech) and washed 
under high-stringency conditions at 50 oC. 
 
Antibodies.  Site-specific polyclonal antibodies against human and mouse SLC17A9 
were prepared by repeatedly injecting GST-fusion polypeptides encoding either M1- I40 
or L8 - R97, respectively.  The antiserum (100 µl) was preabsorbed by incubating it with 
the antigen (1 mg) at 4 °C overnight.  Monoclonal antibodies against synaptotagmin were 
kindly supplied by Dr. M. Takahashi (28).  Anti-His-tag monoclonal antibody was from 
 2 
Novagen.  Alexa Fluor 488-labeled goat anti-rabbit IgG was obtained from Invitrogen 
(Molecular Probes) and colloidal gold conjugated goat anti-rabbit IgG from British 
Biocell International.  
 
Nucleotide binding.  Binding of nucleotides to the purified transporter was assayed by 
UV light illumination according to the published procedures (29).  In brief, the reaction 
was performed in 50 µl reaction mixture containing 20 mM MOPS-Tris, pH 7.0, 50 
mM potassium acetate, 2 mM magnesium acetate, 4 mM KCl, 7 µg protein and 5 µM 
concentration of [α-32P] ATP (15 TBq/mmol).  The reaction mixture was placed in flat 
bottom plastic test tubes, on ice, and at a 5-cm distance from an unfiltered UV lamp 
(UVP Inc., 15W).  After a 10 min illumination, the reaction was terminated by the 
addition of 10 µl of concentrated dissociation buffer to give final concentration of 2% 
SDS and β-mercaptoethanol.  Samples (50 µl) were elecrtrophoresed in the presence of 
SDS and were exposed to an IP image plate. 
 
Immunohistochemistry 
Indirect immunofluorescence microscopy was performed as previously described (30). 
Adrenal glands were obtained from adult C57BL/6 mice perfused intracardially with 4% 
paraformaldehyde in 0.1 M phosphate buffer, pH 7.4.  The first antibody treatment was 
performed with 1:500 diluted antibodies in phosphate-buffered saline (PBS) containing 
0.5% bovine serum albumin (BSA) for 1 h at room temperature. The specimens were 
observed under an Olympus FV300 confocal laser microscope.  
 
Immunoelectronmicroscopy 
The LR White embedding immunogold method used (31). Adult C57BL/6 mice were 
anesthetized with ether and then perfused intracardially with saline, followed by 0.1% 
 3 
glutaraldehyde and 4% paraformaldehyde in 0.1 M phosphate buffer, pH 7.4. Adrenal 
gland was washed with PBS, dehydrated in ethanol series, and then embedded in LR 
White. Ultrathin sections (80 nm) on nickel grids were incubated with PBS containing 2% 
goat serum and 2% BSA for 10min, and then treated with either rabbit antiserum against 
mouse SLC17A9 diluted 1:20 or normal rabbit serum diluted 1:20 for 1hr at room 
temperature.  The sections were washed and treated with secondary antibodies conjugated 
with 10nm colloidal gold diluted 1:50. After washing with sodium cacodylate buffer (pH 
7.4), the sections were postfixed in 2.5% glutaraldehyde in the cacodylate buffer, stained 
sequentially uranyl acetate for 10 min and lead citrate for 1 min.  Specimens were 
observed under a Hitachi H-7100S electron microscope. 
 
Measurement of Δψ and ΔpH by fluorescence quenching. 
Δψ (positive inside) was assayed by measuring the fluorescence quenching of oxonol V as 
described previously (20).   
 
Preparation of chromaffin granule membrane vesicles from bovine adrenal glands 
Chromaffin granules were isolated from bovine adrenal glands by differential centrifugation 
and successive sucrose density gradient centrifugation as described previously (32).  After 
isolation, the granules were immediately disrupted under low osmotic conditions, and the 
resulting membrane vesicles suspension was stocked at -80 oC. 
 
Other procedures.  Polyacrylamide gel electrophoresis in the presence of SDS and 
Western blotting were performed as described (20).  Protein concentration was assayed 
using bovine serum albumin as a standard (33).  
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Supplementary Figures  
Figure 7.  Chromosomal localization and gene organization of SLC17A9.  The exon and 
intron organization of SLC17A9 is also shown.  The open and shaded boxes show 
noncoded and coded exons, respectively. 
 
Figure 8.  Amino acid sequences comparison of members of SLC17 family.  Identical 
residues are indicated by asterisks.  Predicted transmembrane regions are shaded. 
 
Figure 9.  The amino acid sequences of SLC17A9 orthologues are aligned.  Identical 
residues are indicated by asterisks.  Predicted transmembrane regions are shaded.  The 
positions of polypeptide used for preparation of antibody were boxed in red. 
 
Figure 10.  The effect of various anions on Δψ-mediated uptake of [α-32P] ATP by 
SLC17A9 protein. A. The uptake was performed under the standard assay conditions 
except that KCl was replaced with various potassium salts as indicated.  B.  The effects 
of anion species on Cl-–dependent [α-32P]ATP uptake at 2 min in the presence of 4 mM 
KCl plus the indicated potassium salts (4 mM) was measured. 
 
Figure 11.  VNUT orthologues are widely distributed in the animal kingdom.  A 
phylogenetic tree of selected genes encoding VNUT-type transporters from the animal 
kingdom is shown. VNUT from mammals are shown in beige, birds in coral, amphibians 
in dark pink, fish in blue and insects in green. 
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SLC17A1_NPT1        --------------------------------------------------------MQMDNRLPPKKVPGFCSFRYGLSF  24
SLC17A2_NPT3        ----------------------------------------------------------MDGKPATRKGPDFCSLRYGLAL  22
SLC17A3_NPT4        -------------------------------------MATKTELSPTARESKNAQDMQVDETLIPRKVPSLCSARYGIAL  43
SLC17A4_NPThomolog  ---------------------------------------MSTGPDVKATVGDISSDGNLNVAQEECSRKGFCSVRHGLAL  41
SLC17A5_Sialin      ------------------------------------MRSPVRDLARNDGEESTDRTPLLPGAPRAEAAPVCCSARYNLAI  44
SLC17A6_VGLUT2      -----MESVKQRILAPGKEGLKNFAGKSLGQIYRVLEKKQDTGETIELTEDGKPLEVPERKAPLCDCTCFGLPRRYIIAI  75
SLC17A7_VGLUT1      -------------MEFRQEEFRKLAGRALGKLHRLLEKRQEGAETLELSADGRPVTTQTRDPPVVDCTCFGLPRRYIIAI  67
SLC17A8_VGLUT3      MPFKAFDTFKEKILKPGKEGVKNAVGDSLGILQRKIDGTTEEEDNIELNEEGRPVQTSRPSPPLCDCHCCGLPKRYIIAI  80
SLC17A9_VNUT        ----------------------------------------------------------MTLTSRRQDSQEARPECQAWTG  22
                                          *                                        *     *        *  
SLC17A1_NPT1        LVHCCNVIITAQRACLNLTMVVMVNSTDPHGLPNTSTKKLLDN-------------IKNPMYNWSPDIQGIILSSTSYGV  91
SLC17A2_NPT3        IMHFSNFTMITQRVSLSIAIIAMVNTTQQQGLSNASTEGPVADAFNNSSISIKEFDTKASVYQWSPETQGIIFSSINYGI 102
SLC17A3_NPT4        VLHFCNFTTIAQNVIMNITMVAMVNSTSPQSQLNDSSEVLPVDSFGGLSKAPKSLPAKAPVYDWSPQIQGIIFGAVGYGG 123
SLC17A4_NPThomolog  ILQLCNFSIYTQQMNLSIAIPAMVNNTAPPSQPNASTERPSTDSQGYWNETLKEFKAMAPAYDWSPEIQGIILSSLNYGS 121
SLC17A5_Sialin      LAFFGFFIVYALRVNLSVALVDMVDSNTTLEDNRTSKACPEHSAPIKVHHN-----QTGKKYQWDAETQGWILGSFFYGY 119
SLC17A6_VGLUT2      MSGLGFCISFGIRCNLGVAIVDMVNNSTIHRGGKVI--------------------KEKAKFNWDPETVGMIHGSFFWGY 135
SLC17A7_VGLUT1      MSGLGFCISFGIRCNLGVAIVSMVNNSTTHRGGHVV--------------------VQKAQFSWDPETVGLIHGSFFWGY 127
SLC17A8_VGLUT3      MSGLGFCISFGIRCNLGVAIVEMVNNSTVYVDGKPE--------------------IQTAQFNWDPETVGLIHGSFFWGY 140
SLC17A9_VNUT        TLLLGTCLLYCARSSMPICTVSMS-----------------------------------QDFGWNKKEAGIVLSSFFWGY  67
                           *                          *                *   *                     **              
SLC17A1_NPT1        IIIQVPVGYFSGIYSTKKMIGFALCLSSVLSLLIPPAAGIG---VAWVVVCRAVQGAAQGIVATAQFEIYVKWAPPLERG 168
SLC17A2_NPT3        ILTLIPSGYLAGIFGAKKMLGAGLLISSLLTLFTPLAADFG---VILVIMVRTVQGMAQGMAWTGQFTIWAKWAPPLERS 179
SLC17A3_NPT4        ILTMAPSGYLAGRVGTKRVVGISLFATSFLTLCIPLATDFG---IVLLIVTRIVQGLSQSSILGGQFAIWEKWGPPQERS 200
SLC17A4_NPThomolog  FLAPIPSGYVAGIFGAKYVVGAGLFISSFLTLFIPLAANAG---VALLIVLRIVQGIAQVMVLTGQYSIWVKWAPPLERS 198
SLC17A5_Sialin      IITQIPGGYVASKIGGKMLLGFGILGTAVLTLFTPIAADLG---VGPLIVLRALEGLGEGVTFPAMHAMWSSWAPPLERS 196
SLC17A6_VGLUT2      IITQIPGGYIASRLAANRVFGAAILLTSTLNMLIPSAARVH---YGCVIFVRILQGLVEGVTYPACHGIWSKWAPPLERS 212
SLC17A7_VGLUT1      IVTQIPGGFICQKFAANRVFGFAIVATSTLNMLIPSAARVH---YGCVIFVRILQGLVEGVTYPACHGIWSKWAPPLERS 204
SLC17A8_VGLUT3      IMTQIPGGFISNKFAANRVFGAAIFLTSTLNMFIPSAARVH---YGCVMCVRILQGLVEGVTYPACHGMWSKWAPPLERS 217
SLC17A9_VNUT        CLTQVVGGHLGDRIGGEKVILLSASAWGSITAVTPLLAHLSSAHLAFMTFSRILMGLLQGVYFPALTSLLSQKVRESERA 147
                            *   *                *   **  *                                                     
SLC17A1_NPT1        RLTSMSTSGFLLGPFIVLLVTGVICESLGWPMVFYIFGACGCAVCLLWFVLFYDDPKDHPCISISEKEYITSSLVQQV-- 246
SLC17A2_NPT3        KLTTIAGSGSAFGSFIILCVGGLISQALSWPFIFYIFGSTGCVCCLLWFTVIYDDPMHHPCISVREKEHILSSLAQQP-- 257
SLC17A3_NPT4        RLCSIALSGMLLGCFTAILIGGFISETLGWPFVFYIFGGVGCVCCLLWFVVIYDDPVSYPWISTSEKEYIISSLKQQV-- 278
SLC17A4_NPThomolog  QLTTIAGSGSMLGSFIVLLAGGLLCQTIGWPYVFYIFGGIGCACCPLWFPLIYDDPVNHPFISAGEKRYIVCSLAQQD-- 276
SLC17A5_Sialin      KLLSISYAGAQLGTVISLPLSGIICYYMNWTYVFYFFGTIGIFWFLLWIWLVSDTPQKHKRISHYEKEYILSSLRNQL-- 274
SLC17A6_VGLUT2      RLATTSFCGSYAGAVIAMPLAGILVQYTGWSSVFYVYGSFGMVWYMFWLLVSYESPAKHPTITDEERRYIEESIGESANL 292
SLC17A7_VGLUT1      RLATTAFCGSYAGAVVAMPLAGVLVQYSGWSSVFYVYGSFGIFWYLFWLLVSYESPALHPSISEEERKYIEDAIGESAKL 284
SLC17A8_VGLUT3      RLATTSFCGSYAGAVVAMPLAGVLVQYIGWSSVFYIYGMFGIIWYMFWLLQAYECPAAHPTISNEEKTYIETSIGEGANV 297
SLC17A9_VNUT        FTYSIVGAGSQFGTLLTGAVGSLLLEWYGWQSIFYFSGGLTLLWVWYVYRYLLSEKDLILALGVLAQSRPVS-------- 219
                             *                               *                    *           *   *       
SLC17A1_NPT1        --SSSRQSLPIKAILKSLPVWAISIGSFTFFWSHNIMTLYTPMFINSMLHVNIKENGFLSSLPYLFAWICGNLAGQLSDF 324
SLC17A2_NPT3        --SSPGRAVPIKAMVTCLPLWAIFLGFFSHFWLCTIILTYLPTYISTLLHVNIRDSGVLSSLPFIAAASCTILGGQLADF 335
SLC17A3_NPT4        --GSSKQPLPIKAMLRSLPIWSICLGCFSHQWLVSTMVVYIPTYISSVYHVNIRDNGLLSALPFIVAWVIGMVGGYLADF 356
SLC17A4_NPThomolog  --CSPGWSLPIRAMIKSLPLWAILVSYFCEYWLFYTIMAYTPTYISSVLQANLRDSGILSALPFVVGCICIILGGLLADF 354
SLC17A5_Sialin      --SSQK-SVPWVPILKSLPLWAIVVAHFSYNWTFYTLLTLLPTYMKEILRFNVQENGFLSSLPYLGSWLCMILSGQAADN 351
SLC17A6_VGLUT2      LGAMEKFKTPWRKFFTSMPVYAIIVANFCRSWTFYLLLISQPAYFEEVFGFEISKVGMLSAVPHLVMTIIVPIGGQIADF 372
SLC17A7_VGLUT1      MNPLTKFSTPWRRFFTSMPVYAIIVANFCRSWTFYLLLISQPAYFEEVFGFEISKVGLVSALPHLVMTIIVPIGGQIADF 364
SLC17A8_VGLUT3      VS-LSKFSTPWKRFFTSLPVYAIIVANFCRSWTFYLLLISQPAYFEEVFGFAISKVGLLSAVPHMVMTIVVPIGGQLADY 376
SLC17A9_VNUT        ----RHSRVPWRRLFRKPAVWAAVVSQLSAACSFFILLSWLPTFFEETFPDAKG--WIFNVVPWLVAIPASLFSGFLSDH 293
                                *      *                                     *   *  * **                   
SLC17A1_NPT1        FLTRNILSVIAVRKLFTAAGFLLPAIFGVCLPYLSSTFYSIVIFLILAGATGSFCLGGVFINGLDIAPRYFGFIKACSTL 404
SLC17A2_NPT3        LLSRNLLRLITVRKLFSSLGLLLPSICAVALPFVASSYVITIILLILIPGTSNLCDSGFIINTLDIAPRYASFLMGISRG 415
SLC17A3_NPT4        LLTKKFR-LITVRKIATILGSLPSSALIVSLPYLNSGYITATALLTLSCGLSTLCQSGIYINVLDIAPRYSSFLMGASRG 435
SLC17A4_NPThomolog  LLSRKILRLITIRKLFTAIGVLFPSVILVSLPWVRSSHSMTMTFLVLSSAISSFCESGALVNFLDIAPRYTGFLKGLLQV 434
SLC17A5_Sialin      LRAKWNFSTLCVRRIFSLIGMIGPAVFLVAAGFIGCDYSLAVAFLTISTTLGGFCSSGFSINHLDIAPSYAGILLGITNT 431
SLC17A6_VGLUT2      LRSKQILSTTTVRKIMNCGGFGMEATLLLVVGYS-HTRGVAISFLVLAVGFSGFAISGFNVNHLDIAPRYASILMGISNG 451
SLC17A7_VGLUT1      LRSRRIMSTTNVRKLMNCGGFGMEATLLLVVGYS-HSKGVAISFLVLAVGFSGFAISGFNVNHLDIAPRYASILMGISNG 443
SLC17A8_VGLUT3      LRSRQILTTTAVRKIMNCGGFGMEATLLLVVGFS-HTKGVAISFLVLAVGFSGFAISGFNVNHLDIAPRYASILMGISNG 455
SLC17A9_VNUT        LIN-QGYRAITVRKLMQGMGLGLSSVFALCLGHT-SSFCESVVFASASIGLQTFNHSGISVNIQDLAPSCAGFLFGVANT 371
                                            *   *         *            
SLC17A1_NPT1        TGMIGGLIASTLTGLILKQDPESAWFKTFILMAAINVTGLIFYLIVATAEIQDWAKEKQHTRL----------------- 467
SLC17A2_NPT3        FGLIAGIISSTATGFLISQDFESGWRNVFFLSAAVNMFGLVFYLTFGQAELQDWAKERTLTRL----------------- 478
SLC17A3_NPT4        FSSIAPVIVPTVSGFLLSQDPEFGWRNVFFLLFAVNLLGLLFYLIFGEADVQEWAKERKLTRL----------------- 498
SLC17A4_NPThomolog  FAHIAGAISPTAAGFFISQDSEFGWRNVFLLSAAVNISGLVFYLIFGRADVQDWAKEQTFTHL----------------- 497
SLC17A5_Sialin      FATIPGMVGPVIAKSLTPDNTVGEWQTVFYIAAAINVFGAIFFTLFAKGEVQNWALNDHHGHRH---------------- 495
SLC17A6_VGLUT2      VGTLSGMVCPIIVGAMTKNKSREEWQYVFLIAALVHYGGVIFYAIFASGEKQPWADPEETSEEKCGFIHEDELDEETGDI 531
SLC17A7_VGLUT1      VGTLSGMVCPIIVGAMTKHKTREEWQYVFLIASLVHYGGVIFYGVFASGEKQPWAEPEEMSEEKCGFVGHDQLAGSDDSE 523
SLC17A8_VGLUT3      VGTLSGMVCPLIVGAMTRHKTREEWQNVFLIAALVHYSGVIFYGVFASGEKQEWADPENLSEEKCGIIDQDELAEEIELN 535
SLC17A9_VNUT        AGALAGVVGVCLGGYLMKTTG--SWTCLFNLVAIISNLGLCTFLVFGQAQRVDLSSTHEDL------------------- 430
                              
SLC17A1_NPT1        ------------------------------------------------------ 467
SLC17A2_NPT3        ------------------------------------------------------ 478
SLC17A3_NPT4        ------------------------------------------------------ 498
SLC17A4_NPThomolog  ------------------------------------------------------ 497
SLC17A5_Sialin      ------------------------------------------------------ 495
SLC17A6_VGLUT2      TQNYINYGTTKSYGATTQANGGWPSGWEKKEEFVQGEVQDSHSYKDRVDYS--- 582
SLC17A7_VGLUT1      MEDEAEPPGAPPAPPPSYGATHSTFQPPRPPPPVRDY----------------- 560
SLC17A8_VGLUT3      HESFASPKKKMSYGATSQNCEVQKKEWKGQRGATLDEEELTSYQNEERNFSTIS 589
SLC17A9_VNUT        ------------------------------------------------------ 430
                                                                *       *      *   *           *
Human         -------------------------------MTLTSRRQDSQEARPECQAWTGTLLLGTCLLYCARSSMPICTVSMSQDFGW  51
Bovine        -------------------------MQPPPDETRRDAAEDTQWSRPECQVWTGTLLLGTCLLYCARVSMPVCAASMSQDFGW  57
Mouse         --------------MPSQRSSLMQPIPEETRKTPSAAAEDTRWSRPECQAWTGILLLGTCLLYCARVTMPVCTVAMSQDFGW  68
Chicken       -------MAAGGGRNAPVCGGERGSRAPQHDGMWKDGGGEQYWSRPECRAWTAVLLLGTCLLYCARVTVPICAVALSAHFGW  75
Xenopus       VPGNFPMASTSLGGKIAGYQGQLLGGDVQILERLRRSSRDPFWSRWESRVWTATLLVGTCLLYCARANMPICAVAMSEDFGW  82
Zebrafish     -MAVLQKHGKNSCPDLSSIKENPADNIGAAGSQKKWTESSQNWTRPVARIWTVVLLLGTCLLYCARVAMPICAVSMAERFSW  81
Sea urchin    -----------------------------MAMKHTKAKVLAYRYNSERRLWTVLLFVMTSVLFSARTIVPLVAVNLSKEFGW  53
Drosophila    ----------------------MDEKLKYSLLRGELVDTQSIWTRHEKRVWFITLITGTCMLYSTRTTMPLLVPAVASAQKW  60
C  elegans    ---------------------------MLKRPGEYEPPLGKIWTRAESRMWTITMFSGTCVLYASRASLPISAAAVAKEFAW  55
Sea anemone   --------------MEEEDIVLVAKELLSEKESAESKECSSHWPRKDRSQWLITLMASTASIYVTRIIMPLCEPTLALDMGW  68
               *   * **  *****   *   *   *  *               *   *                    *   *  *  
Human         NKKEAGIVLSSFFWGYCLTQVVGGHLGDRIGGEKVILLSASAWGSITAVTP-LLAHLS---SAHLAFMTFSRILMGLLQGVY 129
Bovine        NKKEAGVVLSSFFWGYCLTQVVGGHLGDRIGGEKVILLSASAWGFITVATP-LLAHLG---SAHLAFMTFSRILTGLLQGVY 135
Mouse         NKKEAGIVLSSFFWGYCLTQVVGGHLGDRIGGEKVILLSASAWGFITVTTP-LLAHLG---SGHLAFLTFSRILTGLLQGVY 146
Chicken       DKKQSGVVLSSFFWGYCLTQVIGGHISDQIGGEKVLLLSASAWGFLTFITP-LLTQIT---SAHLVFMTCSRFLMGLLQGVY 153
Xenopus       NKRQSGIVLSSFFWGYCLTQVLGGHLSDKIGGEKVIFLSALTWGLITAMTP-LVAHVT---SVPLILVSVLRFLMGLLQGVH 160
Zebrafish     SKRETGMVLGSFFWGYCFTQVLGGYVSDRVGGEKVMLLSAAAWGAMTAFTP-ILAHFC---SQPIFSMTLSRFLMGLLQGVH 159
Sea urchin    DKTDTGLVLGSFFWGYPIAQIPGGMMSDRIGGDYVIIRAAFIWGVVTLVTP-LVPYLFTTKAGTIMSMTVLRFLMGLTQGVH 134
Drosophila    SKTDSGTVLSSFFWGYTLTQVVGGYFSDRFGGQRVILFAAIGWSLITFLMPTIIWTAGSIKSYAIPFIVAIRILNGALQGVH 142
C  elegans    NKTDSGTVLSCFFWGYALTQVFAGRIADKYGAEKILPYSSLAWTMLTFFTPHLFDFAYWTN-YPLVVLLAVRILTGVCQAFH 136
Sea anemone   NKRESGLVLSSFFWGYLITQIPGGFLSDVYGAERLLLWAVTGCSLSTLVIPLVASQKVT---SPITLVLISRLALGVFQGIY 147
               *   *                        *    *  **       *   *   *    
Human         FPALTSLLSQKVRESERAFTYSIVGAGSQFGTLLTGAVGSLLLEWYGWQSIFYFSGGLTLLWVWYVYRYLLSEK-------- 203
Bovine        FPALTSLLSQKVRESERAFTYSTVGAGSQFGTLVTGAVGSLLLDWYGWPSVFYFSGGLTLLWVGYVYRCLLSERGPSSHLDG 217
Mouse         FPALTSLLSQKVQESERAFTYSTVGAGSQVGTLVTGGVGSVLLDQCGWQSVFYFSGGLTLLWAYYVYRYLLNEK-------- 220
Chicken       FPSLASLLSQRVRESERAFTYSTVGTGSQFGTLVIGAAGSLLLDWYGWESVFYFSGLLTLLWVYCTCKYLLVEK-------- 227
Xenopus       FPALASLFSQRVRETERAFTCSTVGSGSQLGTLVMGGAGSLLLEWYGWESVFYFAGFLALLWGYCLSTYLLKEK-------- 234
Zebrafish     YPSLASLCSQKVVESERGFLMSTVGSGSYLGTLVIGGVGSLMLDLYGWESVFYVSGLLSVLWAYCMWKYLLKGEGP------ 235
Sea urchin    YPSLTSLLSQKVTADKRAYVMSCVFAASSLGTLLTGAIGSIIMDHSNWHYVFYFFGTISIVIATIIQSFSRKQRRK------ 210
Drosophila    FPSMISLTSQNLCPNERSSFFGLLTAGSALGTLLTGIMGSFLLDYFGWSYVFRVIGLMGIAWALVLRYYAMAG--------- 215
C  elegans    IPSLASIVSKHLAAADKGRVFGIVLAGSHWGTVLAGAIGSILIEWIGWRALFQFVGIISLIWCWVFRWVLDRAKGPGG--RS 216
Sea anemone   YPSLYSLLAKSLPISERSSCSAFALAGGPVGSLVIGGLGSLVLARCGWRWVFLSFGSIGLLWAVLWKKIFIDHN-------- 221
                                                        *                 * *  *    *   *   *  *  
Human         ---------DLILALGVLAQSRPVSRHNRVPWRRLFRKPAVWAAVVSQLSAACSFFILLSWLPTFFEETFPDAKGWIFNVVP 276
Bovine        FHVDLPPPSDLILALGILAQGLPVSRHTKVPWRQLFRKPSVWAAIISQLSAACSFFILLSWLPTFFKETFPSSKGWVFNVVP 299
Mouse         ---------DLVLALGFLAQGLPVTKPSKVPWRQLFRKASVWAAICSQLCSACSFFILLSWLPTFFKETFPNSKGWVFNVVP 293
Chicken       ---------DLVIPIDYLRRGISISKQSKVPWKQLFKKAPIWAVIVAQLCTASTFCTLLSWLPTFFKETFPESKGWVFNVVP 300
Xenopus       ---------ERIVTVEDLKKCFAGSAQANGQWKKLFRKAPVWAVILAQLCVASTAFTIFSWMPTFFKERFPESKGWVFNVVP 307
Zebrafish     -----------IITLESLGSAGTQSKIPKRNWLRLFRQPAVCAVIITHLCTASTFFTLLSWLPTFFKDTFPDAKGWVFNVIP 306
Sea urchin    --------TFFSFQNGRAGTRKDDEEKKSLPVLKLLTKKPFWAMAISHLCVIFSYFIIINWMPTFFKEVYPESKGWVYNVLP 284
Drosophila    ----ERNRIINIATPSRLCANKSPAETSAVPWLRYFRRLSFWACVLTHACEMNCFFVLLSWLPTYFHDGFPHAKGWVVNMIP 293
C  elegans    SPLPDEEVLLDKKHDTIESHLAATSPCPSVPWGTLFRHPAFWAAAVAQYTGGNSYSILFNWLPSYFHETFPTAKGFVYNVVP 298
Sea anemone   -------SQMNPTYSPSHTKSEQSSARKNVPWGKIISEPAIWAVVIVHFCHNCMYFTLISWMPTYFHENFPESQGWVFNVVP 296
                                          **                                              *  * 
Human         WLVAIPASLFSGFLSDHLINQGYRAITVRKLMQGMGLGLSSVFALCLGHTSSFCESVVFASASIGLQTFNHSGISVNIQDLA 358
Bovine        WLVAIPASLLSGLLSDHLINQGYRTITVRKFMQVMGLGLSSVFALCLGHTSSFCNSVVFASASIGLQTFNHSGISVNIQDLA 381
Mouse         WMLAIPASLFSGFISDRLISQGYRVITVRKFMQVMGLGLSSIFALCLGHTTSFLKAMIFASASIGFQTFNHSGISVNIQDLA 375
Chicken       WLVAIPTSLFSGFLSDHLINQGYKTITVRKFMQVIGSGVSSVFALCLGQTSSFCKAIVFASASVGLQTFNHSGISVNVQDLA 382
Xenopus       WLFAIPAGILSGLLSDHLITQGYQTVWVRKLMQIVGMGFSSAFIFCLAHTTTYHYAVAFASVALALQTFNHSGITVNVQDLA 389
Zebrafish     WFVAIPSSLFSGCLSDHLISQGFDTASVRKLMQFFSMGVSSVFTLFLCGTTTFPAAVAFVSATMGLTTFSHSGVSVNVQDLA 388
Sea urchin    WLAAIPASIAGGCLGDSLIAHKVPVGISRKIMHTLTVMSS---------------------------SLSNSSTAPNVQDVA 339
Drosophila    WLALPPCTLFAKYLTTRLLAREWHTTTVRKVIQSCCFAAQNLALFVMSRTSDFHTALICMTIIIGGTGFHNNAVTVNPQDLA 375
C  elegans    SLAIVVTSLVAPVMASRALSEGKTVTYTRKLMEGASLLGIAFCLMLVPMTSSFWISLIIFTMAMAARGLHHGGVSVNPHDFA 380
Sea anemone   YIGNFVGKLGGGYVADKMIKMGFSVAFTRKFLETLGTCVPALVLLSTSQAVHFWQALVCMSMALCLCGASTSGSLMNIQDLS 378
              *   *   *      *  *       *     *   *   *         
Human         PSCAGFLFGVANTAGALAGVVGVCLGGYLMETTGS-WTCLFNLVAIISNLGLCTFLVFGQAQRVDLSSTHEDL----- 430
Bovine        PSCAGFLFGVANTAGALAGVVGVCLGGYLIETTGS-WTSVFNLVAAISSLGLCTFLVFGKAQRVDLSPAHEDL----- 453
Mouse         PSCAGFLFGVANTAGALAGVVGVCLSGYLIETTGS-WTCVFHLVAIISNLGLGTFLVFGKAQRVDLVPTHEDL----- 447
Chicken       PSCAGLLFGVGNTGGALLGVVCVYLAGYLMETTGS-WISVFNLVAVVNSVGLCVFLVFGEAQRVDTDSAYIDL----- 454
Xenopus       PTCAGFLFGVANTGGALLGVVLVYLSGYLIETTGS-WSSMFYLVIVVNLMGLVVFLEFAKSERVDTETIHV------- 459
Zebrafish     PSCAGALFGVMNTCGAFTGVIMVYFSGYLIETTGS-WASVFGLITVVNLLGLTTFLSFAEARRVDIDLAKGRYHNIHI 465
Sea urchin    PKHAGSVFGIVNAMGAVQGFVGTYIAGCILHSTGS-WSAVFNMSACVCLFSWVVFTLFAVGTPVI------------- 403
Drosophila    PLHSGSVFGLMNTVGAIPGFLGVYLAGHILELTQS-WPMVFSAAAGINLVGWIIFIVFGSAEAIV------------- 439
C  elegans    PNHAGSVFGVFNACGAITGFVGVYIAGHILEATNNNWSYVFVVTAAQCVVGAMVYTLLGTGQKII------------- 445
Sea anemone   PGFAGSISGVVFTISAIPGVLGVYATGYILHVTNS-WTTVFQLTAVICTAGCAVYNVFAKGHKIL------------- 442
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Table 1.  Energetics of ATP transport. 
 
Inside Outside Ionophores Inside pH Outside pH ATP uptake (%) 
  none   3.1 ± 1.7 
Na+ K+ Val. 7.0 7.0 100.0 
  Nig.   6.4 ± 2.1 
  none   7.6 ± 6.8 
Na+ Na+ Val. 7.0 7.0 6.5 ± 5.0 
  Nig.   4.5 ± 4.1 
  none 7.0 7.0 5.9 ± 2.3 
   5.5 7.0 2.6 ± 0.1 
K+ K+  5.5 7.5 2.4 ± 0.4 
  Val. 7.0 7.0 5.9 ± 5.1 
  Nig.   2.4 ± 3.0 
  none   2.5 ± 0.6 
K+ Na+ Val. 7.0 7.0 3.0 ± 2.1 
  Nig.   3.3 ± 2.8 
 
Na+-trapped proteoliposomes or K+-trapped proteoliposomes was prepared by dilution of 
purified transporter (10 μg protein, 150 μl) into the 3 ml of buffer consisting of 20 mM 
MOPS-tris, pH 7.0, 0.15 M Na-acetate (Na+-trapped proteoliposomes) or 0.15 M K-acetate 
(K+-trapped proteoliposomes), and centrifuged as described.  The pellets were suspended 
in 200 μl of the same buffer.  The proteoliposomes (0.5 μg protein) was added to the buffer 
containing 0.15 M K-acetate and 4 mM KCl or 0.15 M Na-acetate and 4 mM NaCl in the 
presence or absence of listed ionophores (1 μM each).  After incubation for 5 min, ATP 
uptake was started as described.  100 % control corresponded to 16. 0 ± 1.3 nmole/mg 
protein/2 min.  In some experiments, proteoliposomes were prepared in the 20 mM MES, 
pH 5.5, 0.15 M K-acetate and 4 mM KCl.  Then, proteoliposomes were added to the assay 
solution, pH 7.0 or 7.5, 0.15 M K-acetate and 4 mM KCl.  ATP uptake at 2 min was 
measured.   
 
 
